Abrams Bison Investments LLC Has $119.16 Million Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Abrams Bison Investments LLC decreased its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 3.6% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 397,000 shares of the company's stock after selling 15,000 shares during the period. HCA Healthcare comprises approximately 12.3% of Abrams Bison Investments LLC's portfolio, making the stock its 4th biggest holding. Abrams Bison Investments LLC owned about 0.16% of HCA Healthcare worth $119,160,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in HCA. Galvin Gaustad & Stein LLC purchased a new stake in shares of HCA Healthcare in the 4th quarter worth about $18,044,000. NRI Wealth Management LC bought a new stake in HCA Healthcare during the 4th quarter valued at approximately $2,896,000. Czech National Bank raised its position in shares of HCA Healthcare by 4.5% in the 4th quarter. Czech National Bank now owns 39,543 shares of the company's stock worth $11,869,000 after acquiring an additional 1,691 shares in the last quarter. Peak Financial Advisors LLC purchased a new stake in HCA Healthcare in the fourth quarter worth $1,122,000. Finally, Wedge Capital Management L L P NC lifted its position in HCA Healthcare by 7.7% during the fourth quarter. Wedge Capital Management L L P NC now owns 116,075 shares of the company's stock valued at $34,840,000 after buying an additional 8,329 shares during the period. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Stock Performance

NYSE:HCA traded up $4.32 on Friday, hitting $347.36. The stock had a trading volume of 453,484 shares, compared to its average volume of 1,395,253. The business's 50-day simple moving average is $331.50 and its two-hundred day simple moving average is $331.12. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The stock has a market cap of $85.52 billion, a price-to-earnings ratio of 15.81, a price-to-earnings-growth ratio of 1.10 and a beta of 1.48.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, topping the consensus estimate of $5.75 by $0.70. The business had revenue of $18.32 billion for the quarter, compared to analysts' expectations of $18.26 billion. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. The company's revenue was up 5.7% compared to the same quarter last year. During the same quarter last year, the company posted $5.36 EPS. As a group, research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Monday, June 16th will be paid a $0.72 dividend. The ex-dividend date is Monday, June 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.83%. HCA Healthcare's payout ratio is presently 12.81%.

Analysts Set New Price Targets

HCA has been the subject of a number of recent research reports. Baird R W cut shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Truist Financial cut their price target on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating on the stock in a research note on Monday, January 6th. KeyCorp dropped their target price on HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating on the stock in a report on Tuesday, January 7th. Robert W. Baird reaffirmed a "neutral" rating and issued a $336.00 price target (down previously from $396.00) on shares of HCA Healthcare in a research report on Tuesday, April 15th. Finally, Royal Bank of Canada reduced their price objective on shares of HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating for the company in a research note on Monday. One research analyst has rated the stock with a sell rating, six have given a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $381.13.

Insider Activity

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the sale, the senior vice president now directly owns 15,412 shares of the company's stock, valued at $4,971,757.08. This trade represents a 38.22 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Company insiders own 1.30% of the company's stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.